On September 3, 2020 Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) reported that that members of its senior management team will participate in the upcoming investor conferences (Press release, Arena Pharmaceuticals, SEP 3, 2020, View Source [SID1234564435]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Wells Fargo Virtual Healthcare Conference – Presenting on Wednesday, September 9, at 1:20 PM ET
Citi 2020 BioPharma Virtual Conference – Hosting investor meetings on Thursday, September 10
H.C. Wainwright Virtual Global Investment Conference – Presenting on Monday, September 14, at 9:30 AM ET
Cantor Virtual Global Healthcare Conference – Presenting on Wednesday, September 16, at 2:00 PM ET
A live audio webcast of the available presentations will be posted under the investor relations section of Arena’s website at www.arenapharm.com. A replay of the presentations will be available for 30 days following each event.

On September 3, 2020 Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOCs), reported that Sarah Boyce, Avidity’s President and CEO, will participate in a fireside chat at the 2020 Wells Fargo Virtual Healthcare Conference on Thursday, September 10th, 2020 at 9:00 am PT (Press release, Avidity Biosciences, SEP 3, 2020, View Source [SID1234564433]). The conference is being held in a virtual format.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the virtual fireside chat will be available on the Company’s website at www.aviditybiosciences.com in the Investor Resources section. A replay of the fireside chat will be archived on the site for 60 days.

On September 3, 2020 Penumbra, Inc. (NYSE: PEN) reported that its management team is scheduled to present at the Morgan Stanley 18th Annual Global Healthcare Conference on Thursday, September 17, 2020 (Press release, Penumbra, SEP 3, 2020, View Source [SID1234564432]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: Morgan Stanley 18th Annual Global Healthcare Conference
Date: Thursday, September 17, 2020
Time: 10:15am EDT / 7:15am PDT

A webcast of the presentation will be available by visiting the investors’ section of the company’s website at www.penumbrainc.com. The webcast will be available on the company’s website for at least two weeks following the event.

On September 3, 2020 Triple-S Management Corporation (NYSE: GTS) reported that President and Chief Executive Officer Roberto García-Rodríguez, and EVP and Chief Financial Officer Juan José Román-Jiménez, will present at the 2020 Wells Fargo Virtual Healthcare Conference on Thursday, September 10, 2020 via live webcast (Press release, Triple-S Management, SEP 3, 2020, https://www.prnewswire.com/news-releases/triple-s-management-corporation-to-present-at-the-2020-wells-fargo-virtual-healthcare-conference-301124078.html [SID1234564431]). The presentation will begin at 2:40 PM Eastern Time.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Investors and interested parties may listen to the webcast of the presentation by visiting the Company’s investor relations website at www.triplesmanagement.com under the "News and Events" section at the appropriate time. A replay of the presentation will be available on the website following the conference.

On September 3, 2020 Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, reported it will participate in a fireside chat at the Citi 15th Annual Biopharma Virtual Conference on Thursday, September 10, 2020 at 11:40 a.m. ET/8:40 a.m. PT. Dan Faga, Executive Vice President and Chief Operating Officer, will represent Mirati at the event (Press release, Mirati, SEP 3, 2020, View Source [SID1234564430]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The webcast will be available through the "Investors" section of the Mirati website at View Source, and a replay of the webcast will be made available for 90 days following the event.